Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01488721 · ClinicalTrials.gov registry record
Clinical Evaluation of NeoPlex4 Assay and NeoPlex System
A clinical trial, sponsored by Luminex Corporation.
- Completed
- Registry status
- 7,462
- Enrollment target
NCT01488721: Completed study, sponsored by Luminex Corporation.
NCT01488721 is a clinical trial that has completed, run by Luminex Corporation. The registered enrollment target is 7,462 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01488721 has completed, sponsored by Luminex Corporation.
- COMPLETED
- Registry status
- 7,462 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the agreement of clinical performance between the proposed NeoPlex 4 assay and NeoPlex System and the comparator devices in clinical use in newborn screening programs for detection of T4, TSH, 17-OHP and IRT.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,462 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-04 |
What the finished NCT01488721 record still lists
NCT01488721 is an observational study that tracks outcomes without assigning an intervention. Its 7,462 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01488721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01488721 about?
NCT01488721 is a clinical study titled "Clinical Evaluation of NeoPlex4 Assay and NeoPlex System". The purpose of this study is to assess the agreement of clinical performance between the proposed NeoPlex 4 assay and NeoPlex System and the comparator devices in clinical use in newborn screening programs for detection of T4, TSH, 17-OHP and IRT.
What is the current status of trial NCT01488721?
This trial is currently completed. The enrollment target is 7,462 participants. The study started on 2011-12. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01488721?
This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
- NCT06112418 · 7,500 participants · NA
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia